{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-058664","form_type":"8-K","ticker":"HYPR","cik":"0001833769","company_name":"Hyperfine, Inc.","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.571806+00:00","generated_at":"2026-06-02T02:40:29.002355+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Hyperfine Q1 revenue up 25% to $3.30M; net loss narrows to $0.14/share","bullets":["Revenue $3.30M, up 25% YoY from $2.64M; 13 commercial Swoop systems sold in Q1.","Net loss $9.85M ($0.14 loss per share), improved from $12.16M loss ($0.17) in Q1 2023.","Launched 8th gen AI software; began CARE PMR Alzheimer's study; >100 patients in stroke study.","Full-year 2024 revenue guidance $12-15M; cash burn guidance ~$40M.","Gross margin $1.35M; SG&A expense down 26% YoY to $6.43M; R&D $5.57M."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-058664","json":"https://secwatch.observer/filing/0000950170-24-058664.json","markdown":"https://secwatch.observer/filing/0000950170-24-058664.md","text":"https://secwatch.observer/filing/0000950170-24-058664.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1833769/000095017024058664/0000950170-24-058664-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1833769/000095017024058664/hypr-20240513.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T02:40:29.002355+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"f5782752dd8ed780bacc5d43d3bece9f5da2207b","claim":"Hyperfine, Inc. reported first quarter ended March 31, 2024 results: revenue $3.30 million, net income $9.85 million, EPS $0.14 per share. Guidance reaffirmed.","evidence_excerpt":"Stroke Conference and 17 at International Society for Magnetic Resonance Medicine. First Quarter 2024 Financial Results • Revenues for the first quarter of 2024 were $3.30 million, up 25%, compared to $2.64 million in the first quarter of 2023. • Hyperfine, Inc. sold 13 commercial Swoop® systems in the first quarter of 2024. • Gross margin for the first","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1833769/000095017024058664/0000950170-24-058664-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2024"},{"label":"Revenue","value":"$3.30 million"},{"label":"Net income","value":"$9.85 million"},{"label":"EPS","value":"$0.14 per share"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}